News & Updates

PBMs must stop taking advantage of seniors and taxpayers

As much as we can appreciate the ingenuity of entrepreneurs in a free market, programs like Medicare were never intended to pad the pockets of businesses at the expense of consumers and taxpayers…Read More.

‘Cost-cutting’ middlemen reap millions via drug pricing, data show

The Columbus Dispatch
A middleman company hired to keep the state’s prescription-drug prices in check for Ohioans on Medicaid is receiving millions in taxpayer money meant to provide medications for the poor and disabled…Read More.

The Secret Drug Pricing System Middlemen Use to Rake in Millions

Not everybody reads the legal notices inside the Ottumwa Courier. But in January, Iowa pharmacist Mark Frahm noticed something unusual in the paper…Read More.

Brady Says Drug Rebates Should Be Shared With Seniors, But It’s Not Clear How

Inside Health Policy
House Ways & Means Chair Kevin Brady (R-TX) relayed to HHS Secretary Alex Azar Thursday (Sept. 6) his reservations with making health plans share drug rebates at the point of sale…Read More.

Alaska Becomes Latest State To Regulate PBMs

Inside Health Policy
This week Alaska became the latest state to require pharmacy benefit managers be licensed…Read More.

SCPC Praises House Energy and Commerce Leaders’ Ongoing Query of PBM Drug Pricing Role

National LTC Pharmacy Group Thanks Reps. Greg Walden, Michael Burgess and Greg Harper for Issuing New Letters to Nation’s Pharmacy Benefit Managers (PBMs)…Read More.

Delaware Makes Drug Prices More Transparent

Delaware Public Radio
A new law eliminates the so-called gag clause making it easier for pharmacists to tell patients in Delaware about the lowest prices for their prescriptions…Read More.

Consumer Advocates Urge State Insurance Regulators To Use Authority To Fight High Drug Prices

Inside Health Policy
Two consumer advocates recently urged state insurance regulations to weigh using their administrative power — including rate review authority — to control rising drug costs and improve transparency, even if state legislators are unable to push through changes…Read More.

PBMs Are Hogging Our Drug Discounts

The Trump administration has aimed a dagger at the heart of high pharmacy bills: the go-betweens in the supply chain that have been gouging insurers, drugmakers, and, most importantly, consumers…Read More.

To Help Seniors Served by LTC Pharmacies, DIR Fees Should Simply be Prohibited

Morning Consult
Tired of being kept in the dark about the mysterious prescription drug cost pricing process, Congress has proposed a variety of bipartisan legislative reforms designed to shed light on a system seemingly designed at the outset to confuse, befuddle and bewilder…Read More.

Twitter   LinkedIn